I am a researcher funded by Fondation de France, with a background in pharmacological science. With J Guillermet-Guibert, I study the translational interest of class I PI3K small molecule inhibitor in pancreatic cancer and ovarian cancer. For this, we use a panel of cell lines derived for genetically engineered mouse models mimicking the mutational landscape of these disease. Our goal is to provide the proof-of-concept of PI3K inhibitor therapeutic benefit for a further validation in clinical settings. For further information, please click here.